- This line was added.
- This line was removed.
- Formatting was changed.
The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) data collection is part of a larger effort to enhance the TCGA data set with characterized radiological images. The Cancer Imaging Program (CIP) with the cooperation of several of the TCGA tissue-contributing institutions has archived a large portion of the radiological images of the genetically-analyzed KIRC cases.
Clinical, genetic, and pathological data resides in the TCGA data portal, while the radiological data is stored on The Cancer Imaging Archive (TCIA). The data utilizes the same TCGA patient identifiers in both repositories, allowing researchers to explore the correlations between tissue genotype and radiological phenotype. This collection within TCIA is related to the KIRC disease type within TCGA.
CIP TCGA Radiology Initiative
The CIP is supporting multiple projects within the academic community to encourage cross disciplinary research which utilizes the data provided in these resources. More can be learned about this effort on the TCGA Renal Phenotype Research Group page.
We would like to acknowledge the individuals and institutions that have provided data for this collection:
- Memorial Sloan-Kettering Cancer Center, New York, NY - Special thanks to Oguz Akin, MD and Pierre Elnajjar.
- University of Pittsburgh/UPMC, Pittsburgh, PA - Special thanks to Matthew Heller, MD and Rose Jarosz.
- Mayo Clinic, Rochester, MN - Special thanks to Bradley J. Erickson, MD, PhD from the Department of Radiology, Mayo Medical School.
- University of North Carolina, Chapel Hill, NC - Special thanks to J. Keith Smith, M.D., Ph.D. and Shanah Kirk.
- National Cancer Institute, Bethesda, MD - Special thanks to Marston Linehan, M.D. and Rabindra Gautam from the Urologic Oncology Branch.
- M.D. Anderson Cancer Center, Houston TX - Special thanks to Raghu Vikram, M.D., Department of Diagnostic Radiology, and Kimberly M. Garcia, Diagnostic Imaging - Transl. & Clinical Research.
- Roswell Park Cancer Institute, Buffalo NY - Special thanks to Charles Roche, MD; Ermalinda Bonaccio, MD; and Joe Filippini.